MedTrace Logo

SAMBA EU Femoropopliteal Trial

NCT01139177 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2010-06-08

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the safety and performance of the SAMBA Stent and Delivery System in the treatment of femoropopliteal lesions.

Conditions

  • Peripheral Vascular Disease

Interventions

DEVICE

Stenting of atherosclerotic lesion(s)

Stenting of atherosclerotic lesions post pre-dilatation of lesion(s)

Sponsors & Collaborators

  • NovoStent Corporation

    lead INDUSTRY

Principal Investigators

  • Dierk Scheinert, MD · Herz-Zentrum Leipzig

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01139177 on ClinicalTrials.gov